SODIUM PYRROLIDONE CARBOXYLATE

País: Irlanda

Língua: inglês

Origem: HPRA (Health Products Regulatory Authority)

Ingredientes ativos:

SODIUM PYRROLIDONE CARBOXYLATE

Disponível em:

Alliance Pharmaceuticals Ltd.

Código ATC:

D02AX

DCI (Denominação Comum Internacional):

SODIUM PYRROLIDONE CARBOXYLATE

Dosagem:

2.5 %w/w

Forma farmacêutica:

Cream

Tipo de prescrição:

Product not subject to medical prescription

Área terapêutica:

Other emollients and protectives

Status de autorização:

Not marketed

Data de autorização:

2006-08-11

Folheto informativo - Bula

A
A
r
r
t
t
w
w
o
o
r
r
k
k
I
I
n
n
f
f
o
o
r
r
m
m
a
a
t
t
i
i
o
o
n
n
Magenta text, keylines and shading are NOT to be printed
Product Title:
Hydromol Cream leaflet
Date:
12-05-15
Product Size:
126mm x 150mm
Label Number:
15-048
Version 3
Colours Used:
PMS 291, PMS 292, PMS 274
Fonts Used:
Swiss 721, Palatino
Font size (min):
6.5pt
XXXXX
© Alliance Pharmaceuticals Limited. 2015
Hydromol cream is manufactured by: Dales Pharmaceuticals Limited,
Skipton, North Yorkshire, BD23 2RW, UK.
The active ingredient in this medicine is sodium pyrrolidone
carboxylate 2.5%.
The other ingredients are liquid paraffin, isopropyl myristate, sodium
lactate solution, cetomacrogol emulsifying wax, myristyl myristate,
macrogol cetostearyl ether, hydroxybenzoates (parabens)
(E218, E214, E216), phenoxyethanol and purified water.
THIS LEAFLET WAS LAST REVISED: April 2015.
Alliance Pharmaceuticals Limited.
Hydromol is a registered trade mark of Alliance Pharmaceuticals
Limited.
The product licence holder is: Alliance Pharmaceuticals Limited,
C R E A M
Sodium Pyrrolidone Carboxylate
REPORTING OF SIDE EFFECTS
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side effects not listed in this leaflet. You can
also report side effects directly via HPRA Pharmaccovigilance,
Earlsfort Terrace, IRL - Dublin 2; Tel: [phone]; Fax: +353 1
6762517. Website: www.hpra.ie; E-mail: [e-mail]. By
reporting side effects you can help provide more information on the
safety of this medicine.
If your condition worsens consult your doctor or pharmacist.

Características técnicas

SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Sodium pyrrolidone carboxylate 2.5 % w/w Cream
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Sodium Pyrrolidone Carboxylate 2.50 % w/w.
Excipients:
Contains cetostearyl alcohol 4%w/w.
Contains hydroxybenzoates (parabens) approximately 1%w/w: methyl
(E218), ethyl (E214), propyl (E216) and butyl
parahydroxybenzoates.
For a full list of excipients, see section 6.1.
3 PHARMACEUTICAL FORM
Cream
Soft, white oil-in-water cream.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
As a lubricant and hydrating agent in the management of dry skin
conditions such as certain types of eczema,
ichthyosis and senile pruritus.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Route of administration
For topical use only.
ADULTS, CHILDREN AND THE ELDERLY:
Apply liberally to the affected area and massage well into the skin.
Sodium pyrrolidone carboxylate 2.5 % w/w Cream may be used as often as
required.
Sodium pyrrolidone carboxylate 2.5 % w/w Cream is especially
beneficial when used immediately after washing or
bathing, when the resultant warmth of the skin enhances absorption.
4.3 CONTRAINDICATIONS
There are no contraindications except true hypersensitivity to any of
the ingredients.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
If there is aggravation of the condition consult the doctor.
The formulation is not designed for use as a diluent.
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_2_
_9_
_/_
_0_
_9_
_/_
_2_
_0_
_1_
_6_
_C_
_R_
_N_
_ _
_